Effect of food intake on the relative bioavailability of moclobemide (Ro 11-1163). 1988

M P Schoerlin, and M Mayersohn, and B Hoevels, and H Eggers, and M Dellenbach, and J P Pfefen
Clinical Research Department, F. Hoffmann-La Roche & Co., Ltd., Basle, Switzerland.

Twelve healthy adult volunteers received a single 100-mg tablet of moclobemide in an open-label crossover study designed to determine the influence of food on moclobemide absorption. Moclobemide was administered 30 min after a standard breakfast as well as under fasting conditions. Moclobemide absorption was rapid in the absence of food. Bioavailability parameters obtained when drug was taken 30 min after the meal suggested that the rate of absorption was slightly decreased in the presence of food (mean Tmax 0.71 h vs. 1.14 h), while the extent of absorption of moclobemide given with food was unaltered. The decreased absorption rate in the presence of food is not expected to be of clinical significance.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005502 Food Substances taken in by the body to provide nourishment. Foods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001549 Benzamides BENZOIC ACID amides.

Related Publications

M P Schoerlin, and M Mayersohn, and B Hoevels, and H Eggers, and M Dellenbach, and J P Pfefen
January 1990, Acta psychiatrica Scandinavica. Supplementum,
M P Schoerlin, and M Mayersohn, and B Hoevels, and H Eggers, and M Dellenbach, and J P Pfefen
January 1990, Acta psychiatrica Scandinavica. Supplementum,
M P Schoerlin, and M Mayersohn, and B Hoevels, and H Eggers, and M Dellenbach, and J P Pfefen
January 1990, Acta psychiatrica Scandinavica. Supplementum,
M P Schoerlin, and M Mayersohn, and B Hoevels, and H Eggers, and M Dellenbach, and J P Pfefen
January 1990, Acta psychiatrica Scandinavica. Supplementum,
M P Schoerlin, and M Mayersohn, and B Hoevels, and H Eggers, and M Dellenbach, and J P Pfefen
January 1990, Acta psychiatrica Scandinavica. Supplementum,
M P Schoerlin, and M Mayersohn, and B Hoevels, and H Eggers, and M Dellenbach, and J P Pfefen
October 1993, Xenobiotica; the fate of foreign compounds in biological systems,
M P Schoerlin, and M Mayersohn, and B Hoevels, and H Eggers, and M Dellenbach, and J P Pfefen
January 1992, Acta psychiatrica Belgica,
M P Schoerlin, and M Mayersohn, and B Hoevels, and H Eggers, and M Dellenbach, and J P Pfefen
January 1982, International pharmacopsychiatry,
M P Schoerlin, and M Mayersohn, and B Hoevels, and H Eggers, and M Dellenbach, and J P Pfefen
November 1984, Acta psychiatrica Scandinavica,
M P Schoerlin, and M Mayersohn, and B Hoevels, and H Eggers, and M Dellenbach, and J P Pfefen
March 1993, British journal of clinical pharmacology,
Copied contents to your clipboard!